GSEP
GH icon

Golden State Equity Partners’s Guardant Health GH Stock Holding History

Golden State Equity Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-408
Closed -$37.7K – 881
2026
Q1 		$37.7K Buy
+408
New +$41K ﹤0.01% 938

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Golden State Equity Partners's GH Position: Q2 2026 in Review

Golden State Equity Partners sold out of Guardant Health (GH) in Q2 2026, closing a stake of 408 shares — an estimated $37.7K sold.

Golden State Equity Partners first reported a position in GH in Q1 2026 and held it in 1 quarter. The position peaked at $37.7K in Q1 2026. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Golden State Equity Partners reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 408 Guardant Health shares in Q2 2026, an estimated $37.7K.
  • Golden State Equity Partners first reported a position in Guardant Health in Q1 2026 and held it in 1 quarter.
  • Golden State Equity Partners's Guardant Health position peaked at $37.7K in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.